And none of this makes any sense when they said ho
Post# of 36536
They had opened VA hospitals, NY hospital and overseas. So, Excellagen should have been a revenue generating product for them, anyway you look at it. They had all the tools, the investment and local and international deals and yet, we have no idea. We can say Excellagen is 'dead' right now, but the question is why? What happened, when they had everything they said was available to them? This was all in the 10Q in June. So, either Joe made it up or something went wrong with every deal, with the investment money, with everything and that's what we need to know.
At one point, on a call, they said 280 million dollars eventually for Excellagen. That was before Covid. So, with VA hospitals slowly opening, revenue should have been coming in and the fact they had deals with other hospitals and overseas, we SHOULD have seen some revenue at the very least. Not seeing any would mean what the heck did management do with the investment money they got and with all the product they had as well as the money they received for the products from overseas?